|1.||Crump, Michael G: 1 article (01/2015)|
|2.||Kevin Morgan for ARUK consortium: 1 article (01/2015)|
|3.||Zou, Fanggeng: 1 article (01/2015)|
|4.||Aasly, Jan O: 1 article (01/2015)|
|5.||Graff-Radford, Neill R: 1 article (01/2015)|
|6.||Carrasquillo, Minerva M: 1 article (01/2015)|
|7.||Petersen, Ronald C: 1 article (01/2015)|
|8.||Carrasquillo, Sebastian: 1 article (01/2015)|
|9.||Bisceglio, Gina D: 1 article (01/2015)|
|10.||Allen, Mariet: 1 article (01/2015)|
|1.||Alzheimer Disease (Alzheimer's Disease)
01/01/2015 - "We performed a case-control association study of the 5 VAMP1 expression regulating polymorphisms in 4,667 Alzheimer's disease patients and 6,175 controls to determine their contribution to Alzheimer's disease risk. "
01/01/2015 - "Genetically regulated VAMP1 expression in the brain may modify both Alzheimer's disease risk and may contribute to Alzheimer's pathophysiology."
01/01/2015 - "Moreover, we also report a modest protective association for a common VAMP1 polymorphism with Alzheimer's disease risk (OR=0.88, p=0.03). "
01/01/2015 - "We found that polymorphisms associated with increased brain VAMP1 transcript levels conferred higher risk for Alzheimer's disease than those associated with lower VAMP1 transcript levels (p=0.03). "
|2.||Schizophrenia (Dementia Praecox)
09/01/2009 - "Overall the results of our investigation lend further support to atypical antipsychotic medications having the potential to increase levels of neurotrophic and synaptic markers such as NRG-1 and VAMP-1, the former being a strong candidate susceptibility gene for schizophrenia. "
01/01/2011 - "No significant changes in complexin 1, VGAT, complexin 2, VGluT1, dysbindin, NAV2, or VAMP1 mRNA expression were found; however, expression of mRNAs associated with plasticity/cytoskeletal modification (GAP43 and NAV1) was reduced in schizophrenia. "
01/01/2011 - "We also measured mRNA expression of markers associated with synaptic plasticity/neurite outgrowth (growth associated protein 43 [GAP43] and neuronal navigators [NAVs] 1 and 2) and mRNAs of other synaptic-associated proteins previously implicated in schizophrenia: dysbindin and vesicle-associated membrane protein 1 (VAMP1) mRNAs using quantitative polymerase chain reaction. "
|3.||Ganglion Cysts (Ganglion)
12/11/2003 - "VAMP-1 is a specific marker for a set of large ganglion cells and displaced ganglion cells that ramify in the mid-IPL and are likely to have ON-OFF physiology."
12/11/2003 - "However, VAMP-1 expression in the IPL is associated with ganglion cells and does not appear to be localized to presynaptic terminals. "
12/11/2003 - "Labeling for VAMP-1 identified a set of large ganglion cells that ramified in the mid-IPL (inner plexiform layer), suggesting that they may show ON-OFF responses. "
12/11/2003 - "In the inner retina, labeling for VAMP-1 was found in the dendrites, cell bodies, and axons of some ganglion cells, as demonstrated by double labeling with the ganglion cell markers, microtubule-associated protein-1 and Brn-3a. "
|4.||Cocaine-Related Disorders (Cocaine Addiction)
02/01/2012 - "We examined the possible contribution to cocaine dependence of 16 genes involved in the cellular machinery that controls neurotransmitter release: genes encoding proteins of the SNARE complex (STX1A, SNAP25, VAMP1 and VAMP2), fusion control elements (SYT1, SYT2, CPLX1, CPLX2, CPLX3 and CPLX4) and regulatory elements (STXBP1, SYP, SNPH, NSF, NAPA and RAB3A). "
|5.||BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
04/01/2004 - "Decreased capacity of neutrophils to exocytosis in chronic myeloid leukemia is probably caused by the absence of VAMP-1 in these cells."
04/01/2004 - "VAMP-1 associated with membranes of azurophilic and specific/gelatinase granules was absent in peripheral blood neutrophils of patients with chronic myeloid leukemia. "
|1.||Vesicle-Associated Membrane Protein 2 (VAMP2)
|2.||Vesicle-Associated Membrane Protein 1
|3.||Messenger RNA (mRNA)
|4.||Proteins (Proteins, Gene)
|6.||GAP-43 Protein (GAP 43 Protein)
|8.||Neurotransmitter Agents (Neurotransmitter)
|10.||Transcription Factors (Transcription Factor)